CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice
Richmond, Jillian M Masterjohn, Elizabeth Chu, Ruiyin Tedstone, Jennifer Youd, Michele E. Harris, John E.
Richmond, Jillian M
Masterjohn, Elizabeth
Chu, Ruiyin
Tedstone, Jennifer
Youd, Michele E.
Harris, John E.
Citations
Altmetric:
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Journal Article
Publication Date
2017-04-01
Subject Area
Embargo Expiration Date
Link to Full Text
Abstract
Therefore, we sought to determine if targeting CXCR3 could serve as a new treatment for vitiligo.
Source
J Invest Dermatol. 2017 Apr;137(4):982-985. Epub 2017 Jan 23. Link to article on publisher's site
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1016/j.jid.2016.10.048
Permanent Link to this Item
PubMed ID
28126463